445
Views
71
CrossRef citations to date
0
Altmetric
Research Article

Bee Venom Reduces Neuroinflammation in the MPTP-Induced Model of Parkinson's Disease

, , , , , , & show all
Pages 209-217 | Received 14 Oct 2010, Published online: 26 Jan 2011

REFERENCES

  • Baek, Y. H., Huh, J. E., Lee, J. D., Choi, D. Y., & Park, D. S. (2006). Antinociceptive effect and the mechanism of bee venom acupuncture (apipuncture) on inflammatory pain in the rat model of collagen-induced arthritis: Mediation by alpha2-adrenoceptors. Brain Research, 1073–1074, 305–310.
  • Burke, R. E., Cadet, J. L., Kent, J. D., Karanas, A. L., & Jackson-Lewis, V. (1990). An assessment of the validity of densitometric measures of striatal tyrosine hydroxylase-positive fibers: Relationship to apomorphine-induced rotations in 6-hydroxydopamine lesioned rats. Journal of Neuroscience Methods, 35(1), 63–73.
  • Cassarino, D. S., Fall, C. P., Swerdlow, R. H., Smith, T. S., Halvorsen, E. M., Miller, S. W., (1997). Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of parkinson's disease. Biochimica et Biophysica Acta, 1362, 77–86.
  • Castro, H. J., Mendez-Lnocencio, J. I., Omidvar, B., Omidvar, J., Santilli, J., Nielsen, H. S., Jr., (2005). A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis. Allergy Asthma Proceedings, 26, 470–476.
  • Dauer, W., & Przedborski, S. (2003). Parkinson's disease: Mechanisms and models. Neuron, 39, 889–909.
  • Dawson, V. L., Dawson, T. M., Bartley, D. A., Uhl, G. R., & Snyder, S. H. (1993). Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. Journal of Neuroscience, 13, 2651–2661.
  • Dehmer, T., Lindenau, J., Haid, S., Dichgans, J., & Schulz, J. B. (2000). Deficiency of inducible nitric oxide synthase protects against mptp toxicity in vivo. Journal of Neurochemistry, 74, 2213–2216.
  • Doo, A. R., Kim, S. T., Kim, S. N., Moon, W., Yin, C. S., Chae, Y., (2010). Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of parkinson's disease. Neurological Research, 32, 88–91.
  • Franklin, K. B. J., & Paxinos, G. (1997). The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
  • Gao, H. M., Jiang, J., Wilson, B., Zhang, W., Hong, J. S., & Liu, B. (2002). Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to parkinson's disease. Journal of Neurochemistry, 81, 1285–1297.
  • Hirsch, E. C., Breidert, T., Rousselet, E., Hunot, S., Hartmann, A., & Michel, P. P. (2003). The role of glial reaction and inflammation in parkinson's disease. Annals of New York Academy of Science, 991, 214–228.
  • Hunot, S., Boissiere, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., (1996). Nitric oxide synthase and neuronal vulnerability in parkinson's disease. Neuroscience, 72, 355–363.
  • Hunot, S., & Hirsch, E. C. (2003). Neuroinflammatory processes in parkinson's disease. Annals of Neurology, 53, S49–S58; discussion S58–S60.
  • Jackson-Lewis, V., & Przedborski, S. (2007). Protocol for the mptp mouse model of parkinson's disease. Nature Protocol, 2, 141–151.
  • Kwon, Y. B., Kim, H. W., Ham, T. W., Yoon, S. Y., Roh, D. H., Han, H. J., (2003). The anti-inflammatory effect of bee venom stimulation in a mouse air pouch model is mediated by adrenal medullary activity. Journal of Neuroendocrinology, 15, 93–96.
  • Kwon, Y. B., Lee, J. D., Lee, H. J., Han, H. J., Mar, W. C., Kang, S. K., (2001). Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain, 90, 271–280.
  • Lee, J. D., Park, H. J., Chae, Y., & Lim, S. (2005). An overview of bee venom acupuncture in the treatment of arthritis. Evidence Based Complementary and Alternative Medicine, 2, 79–84.
  • Lee, M. S., Pittler, M. H., Shin, B. C., Kong, J. C., & Ernst, E. (2008). Bee venom acupuncture for musculoskeletal pain: A review. Journal of Pain, 9, 289–297.
  • Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., (1999). Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the mptp model of parkinson disease. NatureMedicine, 5, 1403–1409.
  • McGeer, P. L., & McGeer, E. G. (2008). Glial reactions in parkinson's disease. Movement Disorders, 23, 474–483.
  • McGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003). Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Annals of Neurology, 54, 599–604.
  • Namaka, M., Crook, A., Doupe, A., Kler, K., Vasconcelos, M., Klowak, M., (2008). Examining the evidence: Complementary adjunctive therapies for multiple sclerosis. Neurological Research, 30, 710–719.
  • Park, H. J., Lee, S. H., Son, D. J., Oh, K. W., Kim, K. H., Song, H. S., (2004). Antiarthritic effect of bee venom: Inhibition of inflammation mediator generation by suppression of nf-kappab through interaction with the p50 subunit. Arthritis and Rheumatism, 50, 3504–3515.
  • Park, H. J., Son, D. J., Lee, C. W., Choi, M. S., Lee, U. S., Song, H. S., (2007). Melittin inhibits inflammatory target gene expression and mediator generation via interaction with ikappab kinase. Biochemical Pharmacology, 73, 237–247.
  • Przedborski, S., & Vila, M. (2003). The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: A tool to explore the pathogenesis of parkinson's disease. Annals of New York Academy of Science, 991, 189–198.
  • Shinto, L., Calabrese, C., Morris, C., Sinsheimer, S., & Bourdette, D. (2004). Complementary and alternative medicine in multiple sclerosis: Survey of licensed naturopaths. Journal of Alternative and Complementary Medicine, 10, 891–897.
  • Son, D. J., Lee, J. W., Lee, Y. H., Song, H. S., Lee, C. K., & Hong, J. T. (2007). Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacology & Therapeutics, 115, 246–270.
  • Teismann, P., Vila, M., Choi, D. K., Tieu, K., Wu, D. C., Jackson-Lewis, V., (2003). Cox-2 and neurodegeneration in parkinson's disease. Annals of New York Academy of Science, 991, 272–277.
  • Wesselius, T., Heersema, D. J., Mostert, J. P., Heerings, M., Admiraal-Behloul, F., Talebian, A., (2005). A randomized crossover study of bee sting therapy for multiple sclerosis. Neurology, 65, 1764–1768.
  • Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., (2002). Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of parkinson disease. Journal of Neuroscience, 22(5), 1763–1771.
  • Yoon, S. Y., Kim, H. W., Roh, D. H., Kwon, Y. B., Jeong, T. O., Han, H. J., (2005). The anti-inflammatory effect of peripheral bee venom stimulation is mediated by central muscarinic type 2 receptors and activation of sympathetic preganglionic neurons. Brain Research, 1049, 210–216.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.